Subgroup survival analysis showed that LRP1 negatively impacted the OS in male subgroup (p=0.005), with its detrimental effect being more pronounced in patients with advanced BLCA (Stage III-IV, p=0.004). The gene discussed is LRP1; the disease is bladder transitional cell carcinoma.